BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10159788)

  • 21. Vendors worry: will health reform place technology on trial?
    Sabatino F
    Hospitals; 1992 Nov; 66(21):34, 36, 38. PubMed ID: 1427714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On managed care and cutting edge technology.
    Faria MA
    J Med Assoc Ga; 1995 Mar; 84(3):111-2. PubMed ID: 7738442
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical technology--an assessment for the future.
    Kauffman NM
    Am J Med Technol; 1979 Oct; 45(10):910-2. PubMed ID: 115314
    [No Abstract]   [Full Text] [Related]  

  • 24. (Re) opening lines.
    Banko DE; Hinrichsen C; Palazola PA
    Healthc Financ Manage; 2005 Sep; 59(9):60-2, 64. PubMed ID: 16184954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attention at manufacturers' meeting held by increasing regulation over rising costs.
    Richards G
    Hospitals; 1978 Nov; 52(22):20-1. PubMed ID: 700645
    [No Abstract]   [Full Text] [Related]  

  • 26. Sweden. Looking for cost efficiency.
    Med Device Technol; 2001 Mar; 12(2):33. PubMed ID: 11317841
    [No Abstract]   [Full Text] [Related]  

  • 27. Managed care and the business of risk management.
    Clarke RL
    Health Care Manag; 1995 Oct; 2(1):115-23. PubMed ID: 10165626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Point-of-care testing. Cost issues and impact on hospital operations.
    Foster K; Despotis G; Scott MG
    Clin Lab Med; 2001 Jun; 21(2):269-84. PubMed ID: 11396083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes research affecting devices.
    Wagner M
    Mod Healthc; 1991 Feb; 21(6):54. PubMed ID: 10109044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical device technology user fees.
    Bailey PG
    Med Device Technol; 2002 Sep; 13(7):37-8. PubMed ID: 12397834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switzerland's medical technology potential.
    Med Device Technol; 2004 Mar; 15(2):41-2. PubMed ID: 15154339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical technology assessment in the United States of America.
    McCarthy T
    Acta Hosp; 1977; 17(4):314-27. PubMed ID: 10307070
    [No Abstract]   [Full Text] [Related]  

  • 33. What price an additional day of life? A cost-effectiveness study of case management.
    Long MJ; Marshall BS
    Am J Manag Care; 2000 Aug; 6(8):881-6. PubMed ID: 11186500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategic positioning. Part 2: Positioning challenges in an evolving health care marketplace.
    Kauer RT; Berkowitz E
    Physician Exec; 1997; 23(8):46-51. PubMed ID: 10176687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The American difference in health care costs: is there a problem? Is medical necessity the solution?
    Jost TS
    Spec Law Dig Health Care Law; 1999 Dec; (249):9-34. PubMed ID: 10747456
    [No Abstract]   [Full Text] [Related]  

  • 36. Technology new target for cost containment.
    Szalanski A
    MPS; 1979 Aug; 10(8):1, 28-9. PubMed ID: 10324033
    [No Abstract]   [Full Text] [Related]  

  • 37. Economic considerations for device design and development.
    Matthews E
    Med Device Technol; 1997 Nov; 8(9):18-26. PubMed ID: 10174626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving technology thwarts aim of cost analyses.
    Emery S
    Telemed Telehealth Netw; 1997 Feb; 3(1):20-3, 25. PubMed ID: 10165135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The year in preview: government sees device industry up with economy.
    Med Prod Sales; 1984 Feb; 15(2):56-9. PubMed ID: 10265463
    [No Abstract]   [Full Text] [Related]  

  • 40. Looking ahead at technology.
    Iglehart JK
    Hospitals; 1979 Jun; 53(11):88-90. PubMed ID: 107112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.